loadpatents
Patent applications and USPTO patent grants for Goldstein; David Michael.The latest application filed is for "immunoproteasome inhibitors".
Patent | Date |
---|---|
Immunoproteasome Inhibitors App 20220073538 - Lou; Yan ;   et al. | 2022-03-10 |
Immunoproteasome inhibitors Grant 11,225,493 - Lou , et al. January 18, 2 | 2022-01-18 |
Immunoproteasome inhibitors Grant 11,154,563 - Lou , et al. October 26, 2 | 2021-10-26 |
Immunoproteasome Inhibitors App 20200277312 - Lou; Yan ;   et al. | 2020-09-03 |
Immunoproteasome Inhibitors App 20190336515 - Lou; Yan ;   et al. | 2019-11-07 |
Substituted pyrrolo[2,3-b]pyrazines as JAK3 inhibitors Grant 9,676,778 - Goldstein , et al. June 13, 2 | 2017-06-13 |
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors Grant 9,376,438 - Goldstein , et al. June 28, 2 | 2016-06-28 |
Formulations Containing Reversible Covalent Compounds App 20160045503 - Goldstein; David Michael ;   et al. | 2016-02-18 |
Tyrosine Kinase Inhibitors App 20150353562 - GOLDSTEIN; David Michael | 2015-12-10 |
Tyrosine Kinase Inhibitors App 20150353557 - Goldstein; David Michael ;   et al. | 2015-12-10 |
Azaindole Derivatives As Jak3 Inhibitors App 20150291600 - Goldstein; David Michael ;   et al. | 2015-10-15 |
Tyrosine kinase inhibitors Grant 9,090,621 - Goldstein July 28, 2 | 2015-07-28 |
Formulations Comprising Ibrutinib App 20150140085 - Goldstein; David Michael | 2015-05-21 |
Tyrosine kinase inhibitors Grant 8,962,635 - Goldstein February 24, 2 | 2015-02-24 |
Tyrosine kinase inhibitors Grant 8,962,831 - Goldstein February 24, 2 | 2015-02-24 |
Benzotriazole kinase modulators Grant 8,962,622 - Goldstein , et al. February 24, 2 | 2015-02-24 |
Tyrosine kinase inhibitors Grant 8,957,080 - Goldstein , et al. February 17, 2 | 2015-02-17 |
Tyrosine kinase inhibitors Grant 8,946,241 - Goldstein February 3, 2 | 2015-02-03 |
Tyrosine Kinase Inhibitors App 20140336382 - GOLDSTEIN; David Michael | 2014-11-13 |
Kinase Inhibitors App 20140323464 - Taunton, JR.; John William ;   et al. | 2014-10-30 |
Tyrosine Kinase Inhibitors App 20140309223 - GOLDSTEIN; David Michael | 2014-10-16 |
Tyrosine Kinase Inhibitors App 20140303161 - GOLDSTEIN; David Michael ;   et al. | 2014-10-09 |
Tyrosine Kinase Inhibitors App 20140303190 - GOLDSTEIN; David Michael | 2014-10-09 |
Pyrazolopyrimidine Derivatives As Tyrosine Kinase Inhibitors App 20140221398 - Goldstein; David Michael ;   et al. | 2014-08-07 |
Tyrosine kinase inhibitors Grant 8,759,358 - Goldstein June 24, 2 | 2014-06-24 |
Tyrosine Kinase Inhibitors App 20140107151 - Goldstein; David Michael ;   et al. | 2014-04-17 |
Tyrosine Kinase Inhibitors App 20140094459 - Goldstein; David Michael ;   et al. | 2014-04-03 |
Tyrosine kinase inhibitors Grant 8,673,925 - Goldstein March 18, 2 | 2014-03-18 |
Azaindole Derivatives As Tyrosine Kinase Inhibitors App 20140073626 - Goldstein; David Michael ;   et al. | 2014-03-13 |
Inhibitors of JNK Grant 8,642,601 - Arzeno , et al. February 4, 2 | 2014-02-04 |
JNK modulators Grant 8,399,462 - Dunn , et al. March 19, 2 | 2013-03-19 |
Pyrimidinyl pyridone inhibitors of kinases Grant 8,268,840 - Brookfield , et al. September 18, 2 | 2012-09-18 |
Inhibitors of JNK Grant 8,183,254 - Arzeno , et al. May 22, 2 | 2012-05-22 |
Dihydroquinone and dihydronaphthridine inhibitors of JNK Grant 8,163,906 - Abbot , et al. April 24, 2 | 2012-04-24 |
Inhibitors of JNK App 20110301171 - Arzeno; Humberto Bartolome ;   et al. | 2011-12-08 |
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones Grant 7,750,016 - Goldstein July 6, 2 | 2010-07-06 |
Inhibitors of JNK App 20090318484 - Arzeno; Humberto Bartolome ;   et al. | 2009-12-24 |
Pyrimidinyl pyridone inhibitors of kinases App 20090270389 - Brookfield; Frederick ;   et al. | 2009-10-29 |
Prediction of bone marrow toxicity App 20090208991 - Ludwig Bitter; Hans Marcus ;   et al. | 2009-08-20 |
Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors Grant 7,566,708 - Arora , et al. July 28, 2 | 2009-07-28 |
Prediction Of Genotoxicity App 20090181415 - Bitter; Hans Marcus Ludwig ;   et al. | 2009-07-16 |
Methods of inhibiting BTK and SYK protein kinases Grant 7,501,410 - Goldstein , et al. March 10, 2 | 2009-03-10 |
Indazole derivatives and methods for using the same Grant 7,495,015 - Arora , et al. February 24, 2 | 2009-02-24 |
Substituted quinazoline compounds useful as p38 kinase inhibitors Grant 7,456,185 - Dunn , et al. November 25, 2 | 2008-11-25 |
Dihydroquinone and dihydronaphthridine inhibitors of JNK App 20080287458 - Abbot; Sarah C. ;   et al. | 2008-11-20 |
Substituted pyrazolo [3,4-d] pyrimidines and methods of using the same Grant 7,452,880 - Arora , et al. November 18, 2 | 2008-11-18 |
6-Substituted pyrido-pyrimidines Grant 7,449,581 - Chen , et al. November 11, 2 | 2008-11-11 |
Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same Grant 7,435,731 - Arora , et al. October 14, 2 | 2008-10-14 |
JNK modulators App 20080146565 - Dunn; James Patrick ;   et al. | 2008-06-19 |
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones App 20080119497 - Goldstein; David Michael | 2008-05-22 |
Benzotriazole kinase modulators App 20080103142 - Goldstein; David Michael ;   et al. | 2008-05-01 |
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones Grant 7,348,331 - Goldstein March 25, 2 | 2008-03-25 |
6-Alkoxy-pyrido-pyrimidines Grant 7,320,987 - Goldstein , et al. January 22, 2 | 2008-01-22 |
Imidazo-substituted compounds as p38 kinase inhibitors Grant 7,285,561 - Goldstein , et al. October 23, 2 | 2007-10-23 |
Imidazo-substituted compounds as p38 kinase inhibitors Grant 7,285,559 - Goldstein , et al. October 23, 2 | 2007-10-23 |
Methods of inhibiting BTK and SYK protein kinases App 20070219195 - Goldstein; David Michael ;   et al. | 2007-09-20 |
p38 MAP kinase inhibitors and methods for using the same App 20070203160 - Arora; Nidhi ;   et al. | 2007-08-30 |
Substituted quinazoline compounds useful as p38 kinase inhibitors App 20070167471 - Dunn; James Patrick ;   et al. | 2007-07-19 |
6-Alkoxy-pyrido-pyrimidines App 20070167484 - Goldstein; David Michael ;   et al. | 2007-07-19 |
Substituted quinazoline compounds useful as p38 kinase inhibitors Grant 7,238,698 - Dunn , et al. July 3, 2 | 2007-07-03 |
Substituted 7-aza-quinazoline compounds useful as p38 kinase inhibitors App 20070135459 - Dewdney; Nolan James ;   et al. | 2007-06-14 |
6-Substituted pyrido-pyrimidines App 20070135458 - Chen; Jian Jeffrey ;   et al. | 2007-06-14 |
6-alkoxy-pyrido-pyrimidines Grant 7,196,097 - Goldstein , et al. March 27, 2 | 2007-03-27 |
Substituted 7-azaquinazoline compounds useful as p38 kinase inhibitors Grant 7,189,731 - Dewdney , et al. March 13, 2 | 2007-03-13 |
6-substituted pyrido-pyrimidines Grant 7,169,794 - Chen , et al. January 30, 2 | 2007-01-30 |
6-alkoxy-pyrido-pyrimidines App 20060276646 - Goldstein; David Michael ;   et al. | 2006-12-07 |
Imidazo-substituted compounds as P38 kinase inhibitors App 20060252784 - Goldstein; David Michael ;   et al. | 2006-11-09 |
6-alkoxy-pyrido-pyrimidines Grant 7,105,525 - Goldstein , et al. September 12, 2 | 2006-09-12 |
Imidazo-substituted compounds as p38 kinase inhibitors Grant 7,081,462 - Goldstein , et al. July 25, 2 | 2006-07-25 |
Pyrazole derivatives-p38 MAP kinase inhibitors Grant 6,979,693 - Goldstein , et al. December 27, 2 | 2005-12-27 |
6-alkoxy-pyrido-pyridine Grant 6,965,030 - Goldstein , et al. November 15, 2 | 2005-11-15 |
Indazole derivatives and methods for using the same App 20050215595 - Arora, Nidhi ;   et al. | 2005-09-29 |
Imidazo-substituted compounds as p38 kinase inhibitors Grant 6,949,560 - Goldstein , et al. September 27, 2 | 2005-09-27 |
6-Alkoxy-pyrido-pyrimidines App 20050203300 - Goldstein, David Michael ;   et al. | 2005-09-15 |
Heteroaryl-fused pyrazolo derivatives and methods for using the same App 20050203091 - Arora, Nidhi ;   et al. | 2005-09-15 |
Fused-pyrazolo pyrimidine and pyrazolo pyrimidinone derivatives and methods for using the same App 20050197340 - Arora, Nidhi ;   et al. | 2005-09-08 |
Imidazo-substituted compounds as p38 kinase inhibitors App 20050197352 - Goldstein, David Michael ;   et al. | 2005-09-08 |
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones App 20050107408 - Goldstein, David Michael | 2005-05-19 |
Methods of treating p38 kinase-mediated disorders with pyrido[2,3-d]pyrimidin-7-one compounds Grant 6,861,423 - Chen , et al. March 1, 2 | 2005-03-01 |
Substituted quinazoline compounds useful as P38 kinase inhibitors App 20040209904 - Dunn, James Patrick ;   et al. | 2004-10-21 |
Substituted 7-azaquinazoline compounds useful as p38 kinase inhibitors App 20040209903 - Dewdney, Nolan James ;   et al. | 2004-10-21 |
7-oxo-pyridopyrimidines (II) App 20040192709 - Arzeno, Humberto Bartolome ;   et al. | 2004-09-30 |
7-oxo-pyridopyrimidines (II) Grant 6,753,427 - Arzeno , et al. June 22, 2 | 2004-06-22 |
6-Substituted pyrido-pyrimidines App 20040116698 - Chen, Jian Jeffrey ;   et al. | 2004-06-17 |
6-alkoxy-pyrido-pyrimidines App 20040038999 - Goldstein, David Michael ;   et al. | 2004-02-26 |
6-substituted pyrido-pyrimidines Grant 6,696,566 - Chen , et al. February 24, 2 | 2004-02-24 |
Aminopyrrole compounds Grant 6,696,471 - Goldstein , et al. February 24, 2 | 2004-02-24 |
Imidazo-substituted compounds as p38 kinase inhibitors App 20030232847 - Goldstein, David Michael ;   et al. | 2003-12-18 |
Alkylamino-substituted bicyclic nitrogen heterocycles Grant 6,642,241 - Dunn , et al. November 4, 2 | 2003-11-04 |
p38 map kinase inhibitors Grant 6,630,485 - Cheng , et al. October 7, 2 | 2003-10-07 |
6-Substituted pyrido-pyrimidines App 20030171584 - Chen, Jian Jeffrey ;   et al. | 2003-09-11 |
7-oxo-pyridopyrimidines (I) App 20030153586 - Chen, Jian Jeffrey ;   et al. | 2003-08-14 |
7-oxo-pyridopyrimidines (II) App 20030144307 - Arzeno, Humberto Bartolome ;   et al. | 2003-07-31 |
p38 MAP kinase inhibitors App 20030139462 - Cheng, Soan ;   et al. | 2003-07-24 |
Aminopyrrole compounds App 20030130319 - Goldstein, David Michael ;   et al. | 2003-07-10 |
7-oxo-pyridopyrimidines (II) Grant 6,518,276 - Arzeno , et al. February 11, 2 | 2003-02-11 |
Pyrazole derivatives - p38 MAP kinase inhibitors App 20030018051 - Goldstein, David Michael ;   et al. | 2003-01-23 |
7-oxo-pyridopyrimidines (I) Grant 6,506,749 - Chen , et al. January 14, 2 | 2003-01-14 |
p38 MAP kinase inhibitors Grant 6,479,507 - Cheng , et al. November 12, 2 | 2002-11-12 |
Pyrazole derivatives - p38 MAP kinase inhibitors App 20020156114 - Goldstein, David Michael ;   et al. | 2002-10-24 |
7-oxo-pyridopyrimidines (I) App 20020137756 - Chen, Jian Jeffrey ;   et al. | 2002-09-26 |
Heteroalkylamino-substituted bicyclic nitrogen heterocycles Grant 6,451,804 - Dunn , et al. September 17, 2 | 2002-09-17 |
Pyrazole derivatives P38 MAP kinase inhibitors Grant 6,444,696 - Goldstein , et al. September 3, 2 | 2002-09-03 |
Pyrazole derivatives P38 MAP kinase inhibitors App 20020103245 - Goldstein, David Michael ;   et al. | 2002-08-01 |
7-oxo-pyridopyrimidines (II) App 20020055513 - Arzeno, Humberto Bartolome ;   et al. | 2002-05-09 |
p38 map kinase inhibitors App 20020013354 - Cheng, Soan ;   et al. | 2002-01-31 |
p38 MAP kinase inhibitors App 20010044538 - Cheng, Soan ;   et al. | 2001-11-22 |
Pyrazole derivatives P-38 MAP kinase inhibitors Grant 6,316,466 - Goldstein , et al. November 13, 2 | 2001-11-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.